Evaluation of the natural course of thyroid nodules in patients with acromegaly

Pituitary. 2019 Feb;22(1):29-36. doi: 10.1007/s11102-018-0923-1.

Abstract

Purpose: To investigate the nodular thyroid disease (NTD) and the natural course of thyroid nodules in patients with acromegaly.

Methods: 138 patients with acromegaly (73 F/65 M), whose initial thyroid ultrasonography performed in our university hospital, were included in this study. The frequencies of NTD, papillary thyroid cancer (PTC) and associated factors on nodule formation were investigated at initial assessment. Patients who had NTD continued to follow-up (n = 56) were re-evaluated with a ultrasonography performed after a mean 7-years follow-up period. The nodule size changes were compared with the initial data and the factors affecting nodule growth were investigated.

Results: The frequency of NTD was found 69%. Patients with NTD were older (p = 0.05), with higher baseline IGF-1%ULN (upper limit of normal) (p = 0.01). In patients with NTD, the majority had similar nodule size (45%), decreased nodule size in 30% and nodule growth in 25%. In patients with active acromegaly at last visit, nodule growth was more significant (p < 0.001). For one unit change in the IGF-1 levels, nodule growth increased by 1.01 folds and presence of active acromegaly disease was related with ninefolds increase in nodule growth. The frequency of PTC was 14% in patients with nodule growth and PTC was diagnosed 11% of all acromegalic patients.

Conclusion: Both NTD and nodule growth is more frequent in active acromegalic patients. Thyroid nodules may show dynamic changes according to the disease activity and nodule growth should be closely monitored due to the risk of malignancy in patients with active acromegaly disease.

Keywords: Acromegaly; IGF-1; Natural course; Papillary thyroid carcinoma; Thyroid nodule growth.

MeSH terms

  • Acromegaly / metabolism*
  • Aged
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Receptors, Somatostatin / metabolism*
  • Thyroid Nodule / metabolism*

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • GFAP protein, human
  • Glial Fibrillary Acidic Protein
  • Receptors, Somatostatin